Adding the dual checkpoint inhibitor regimen of ipilimumab (Yervoy) and nivolumab (Opdivo) to percutaneous hepatic perfusion significantly reduced the risk of disease progression or death in ...

Clinical utility may be greatest with careful patient selection, given frailty-associated toxicity and potential endpoint inflation in indolent tumors, warranting larger validation cohorts and ...

Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...

OU Health Stephenson Cancer Center told News 9 on Sunday that it is the only site in Oklahoma that offers a new cell therapy to treat advanced melanoma. OU Health Stephenson Cancer Center told News 9 ...

A new personalized skin cancer treatment is showing success in preventing the return of high-risk melanoma. Five-year study results were announced on Tuesday by pharmaceutical companies Moderna Inc ...

Melanoma usually appears in locations where the skin receives frequent sun exposure, like the face, neck, shoulders, arms and legs. These melanomas are often linked to ultraviolet (UV) damage and may ...

After surgery to decrease the odds of the cancer returning If a person is unable to undergo surgery, for example if their health does not allow it or if the melanoma is in a hard-to-reach place To ...

Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAFV600E Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H Homologous recombination deficiency ...

Perry Bamonte, longtime guitarist and keyboardist for The Cure, died over the Christmas holiday. He was 65. The band released a statement on their official website confirming Bamonte's death, noting ...

Using less ipilimumab appears to make melanoma immunotherapy both safer and more effective, with dramatically better response and survival outcomes. The findings suggest that reducing side effects may ...